Uveal melanoma
MJ Jager, CL Shields, CM Cebulla… - Nature reviews Disease …, 2020 - nature.com
Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. UMs
are usually initiated by a mutation in GNAQ or GNA11, unlike cutaneous melanomas, which …
are usually initiated by a mutation in GNAQ or GNA11, unlike cutaneous melanomas, which …
Use of family history and genetic testing to determine risk of colorectal cancer
F Kastrinos, NJ Samadder, RW Burt - Gastroenterology, 2020 - Elsevier
Approximately 35% of patients with colorectal cancer (CRC) have a family history of the
disease attributed to genetic factors, common exposures, or both. Some families with a …
disease attributed to genetic factors, common exposures, or both. Some families with a …
[HTML][HTML] Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline
PA Konstantinopoulos, B Norquist… - Journal of clinical …, 2020 - ncbi.nlm.nih.gov
PURPOSE To provide recommendations on genetic and tumor testing for women diagnosed
with epithelial ovarian cancer based on available evidence and expert consensus …
with epithelial ovarian cancer based on available evidence and expert consensus …
[HTML][HTML] Identification of the 3-lncRNA signature as a prognostic biomarker for colorectal cancer
S Liu, Q Cao, G An, B Yan, L Lei - International journal of molecular …, 2020 - mdpi.com
Colorectal cancer (CRC) is one of the most common malignant carcinomas in the world, and
metastasis is the main cause of CRC-related death. However, the molecular network …
metastasis is the main cause of CRC-related death. However, the molecular network …
[HTML][HTML] Emerging roles of RNA 3′-end cleavage and polyadenylation in pathogenesis, diagnosis and therapy of human disorders
J Nourse, S Spada, S Danckwardt - Biomolecules, 2020 - mdpi.com
A crucial feature of gene expression involves RNA processing to produce 3′ ends through
a process termed 3′ end cleavage and polyadenylation (CPA). This ensures the nascent …
a process termed 3′ end cleavage and polyadenylation (CPA). This ensures the nascent …
Whole exome sequencing identifies candidate genes associated with hereditary predisposition to uveal melanoma
MH Abdel-Rahman, KM Sample, R Pilarski, T Walsh… - Ophthalmology, 2020 - Elsevier
Purpose To identify susceptibility genes associated with hereditary predisposition to uveal
melanoma (UM) in patients with no detectable germline BAP1 alterations. Design …
melanoma (UM) in patients with no detectable germline BAP1 alterations. Design …
No evidence of increased risk of breast cancer in women with Lynch syndrome identified by multigene panel testing
J Stoll, E Rosenthal, S Cummings, J Willmott… - JCO precision …, 2020 - ascopubs.org
PURPOSE Prior estimates of breast cancer risk in women with Lynch syndrome (LS) range
from population risk to 18-fold increased risk with reported differences by gene. Here, breast …
from population risk to 18-fold increased risk with reported differences by gene. Here, breast …
A new comprehensive colorectal cancer risk prediction model incorporating family history, personal characteristics, and environmental factors
Purpose: Reducing colorectal cancer incidence and mortality through early detection would
improve efficacy if targeted. We developed a colorectal cancer risk prediction model …
improve efficacy if targeted. We developed a colorectal cancer risk prediction model …
Penetrance of colorectal cancer among mismatch repair gene mutation carriers: a meta-analysis
Background Lynch syndrome, the most common colorectal cancer (CRC) syndrome, is
caused by germline mismatch repair (MMR) genes. Precise estimates of age-specific risks …
caused by germline mismatch repair (MMR) genes. Precise estimates of age-specific risks …
[HTML][HTML] Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair …
S Mishima, H Taniguchi, K Akagi, E Baba… - International Journal of …, 2020 - Springer
Background Novel therapeutic agents have improved survival outcomes in patients with
advanced solid tumors. In parallel, the development of predictive biomarkers to identify …
advanced solid tumors. In parallel, the development of predictive biomarkers to identify …